PACB (STOCKS)
Pacific Biosciences of California, Inc.
$1.320200
+0.010200 (+0.78%)
Prev close: $1.310000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Christian O. Henry
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $408.44M
- Employees
- 575
- P/E (TTM)
- -3.09
- P/B (TTM)
- 171.92
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
5
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.12 | $-0.14 | +0.0175 | +12.73% |
|
Dec 2025 (Q4)
|
$-0.12 | $-0.15 | +0.0305 | +20.27% |
|
Sep 2025 (Q3)
|
$-0.13 | $-0.16 | +0.0250 | +16.13% |
|
Jun 2025 (Q2)
|
$-0.14 | $-0.17 | +0.0334 | +19.26% |
Financial Statements
| Revenues | $160.03M |
| Benefits Costs and Expenses | $287.80M |
| Cost Of Revenue | $100.04M |
| Costs And Expenses | $287.80M |
| Gross Profit | $59.99M |
| Operating Expenses | $193.28M |
| Selling, General, and Administrative Expenses | $132.48M |
| Research and Development | $87.86M |
| Operating Income/Loss | -$133.28M |
| Income/Loss From Continuing Operations After Tax | -$128.58M |
| Income/Loss From Continuing Operations Before Tax | -$127.77M |
| Income Tax Expense/Benefit | $804.00K |
| Net Income/Loss | -$128.58M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$128.58M |
| Net Income/Loss Available To Common Stockholders, Basic | -$128.58M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.43 |
| Diluted Earnings Per Share | -$0.43 |
| Basic Average Shares | 907,481,000 |
| Diluted Average Shares | 907,481,000 |
| Assets | $782.37M |
| Current Assets | $369.52M |
| Inventory | $51.02M |
| Other Current Assets | $318.50M |
| Noncurrent Assets | $412.85M |
| Fixed Assets | $24.38M |
| Intangible Assets | $14.10M |
| Other Non-current Assets | $374.37M |
| Liabilities | $780.00M |
| Current Liabilities | $65.36M |
| Accounts Payable | $13.61M |
| Other Current Liabilities | $51.75M |
| Noncurrent Liabilities | $714.64M |
| Equity | $2.37M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.37M |
| Liabilities And Equity | $782.37M |
| Net Cash Flow From Operating Activities | -$111.84M |
| Net Cash Flow From Operating Activities, Continuing | -$111.84M |
| Net Cash Flow From Investing Activities | $106.07M |
| Net Cash Flow From Investing Activities, Continuing | $106.07M |
| Net Cash Flow From Financing Activities | $2.91M |
| Net Cash Flow From Financing Activities, Continuing | $2.91M |
| Net Cash Flow | -$2.87M |
| Net Cash Flow, Continuing | -$2.87M |
| Comprehensive Income/Loss | -$129.10M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$129.10M |
| Other Comprehensive Income/Loss | -$129.10M |
| Other Comprehensive Income/Loss Attributable To Parent | -$528.00K |